Clinical Trial Update: Ranibizumab Therapy for Non-arteritic Ischemic Optic Neuropathy [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating ranibizumab for nonarteritic anterior ischemic optic neuropathy has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonarteritic Anterior Ischemic Optic Neuropathy

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Nonarteritic Anterior Ischemic Optic Neuropathy | Phase 1 | Status: COMPLETED | Results posted: 2016-07-25